Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
NCT01223729
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
67
Enrollment
OTHER
Sponsor class
Conditions
Minimal Hepatic Encephalopathy
Interventions
DRUG:
Acetyl-L-Carnitine
OTHER:
placebo
Sponsor
University of Catania